Treatment or prophylaxis of insulin-producing cell graft...

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 39/395 (2006.01) A61K 31/133 (2006.01) A61K 31/365 (2006.01) A61K 31/436 (2006.01) A61K 39/00 (2006.01) A61K 45/06 (2006.01) A61P 5/50 (2006.01)

Patent

CA 2445605

A pharmaceutical combination comprising an accelerated lymphocyte homing agent in free form or in pharmaceutically acceptable salt form, and one or more compounds selected from the group consisting of an antibody to the IL-2 receptor, an immunosuppressive macrocylic lactone and a soluble human complement inhibitor is used to treat or prevent insulin-producing cell graft rejection.

La présente invention concerne une combinaison pharmaceutique qui renferme un agent d'écotaxie lymphocytaire accélérée sous forme libre ou sous forme de sel pharmaceutiquement acceptable et un ou plusieurs composés sélectionnés dans le groupe formé par un anticorps dirigé contre le récepteur IL-2, une lactone macrocyclique immunosuppressive et un inhibiteur complémentaire humain soluble. Cette combinaison pharmaceutique est utilisée pour traiter ou prévenir le rejet des greffes de cellules produisant de l'insuline.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Treatment or prophylaxis of insulin-producing cell graft... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Treatment or prophylaxis of insulin-producing cell graft..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treatment or prophylaxis of insulin-producing cell graft... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1546485

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.